×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

La SFCO présente : un webinar autour du cancer de l'ovaire

Programme

Modérateur: Pr Fabrice Lécuru

18:00
Les données actuelles françaises
Dr Marie Osdoit
 
18:20
Les critères de qualité en chirurgie
Pr Denis Querleu (ESGO)
 
18:40
Le parcours de soins
Dr Manuel Rodrigues
 
19:00 Réponses aux questions et Débat/Discussion


 

Shooting date : 2020-06-24
Last update : 2020-06-25
7 comments
Join the Discussion
See previous comments (3)
  • lylia H. @Michel L.
    Dr. Manuel Rodrigues:
    Non. Si la patiente a été sous antiPARP en 1ere ligne ("adjuvant") et qu'elle rechute à plus de 6 mois, il n'y a pas de preuve de l'intérêt de remettre sous antiPARP. Par contre il y a l'essai OREO (remise sous PARP ou placebo) qui évalue cette question actuellement et bientôt d'autres essais

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • lylia H. @Mohamed K
      Dr. Denis Querieu
      ils sont fondés sur la littérature, et finalement pas trop exigeants (20 par an c'est 2 par mois environ)

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • lylia H.
        @Eno L
        Dr. Denis Querieu :
        réglementations trop différentes pour légiférer facilement ; en fait, il existe déjà fellowship ESGO 2 ans et examen ESGO et en conséquence un titre de gynéco oncologue européen

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • lylia H. @Yann R
          Dr. Manuel Rodrigues
          très bonne question. C'est majeur car cette prise en charge est un vrai rouleau compresseur mais on manque de moyens humains

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          • lylia H. @Carlos M.
            Dr; Manuel Rodrigues
            Les PARPinh sont des drogues indispensables si BRCAm. Chez les BRCA sauvages c'est important aussi mais moins. A ce jour il faut etre prudent, ces drogues sont utiles pendant une ligne. Il n'y a aucune preuve que de redonner un PARP soit utile => essai OREO

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            • lylia H. @Florient M
              Dr. Manuel Rodrigues
              dans le doute oui, il y a eu des cas. Ne serait ce que sur un mauvais echantillonage anapath. Il n'y a guère que les mucineux évidents pour lesquels on a pas de BRCA

                Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
                Your browser doesn't have Flash, Silverlight or HTML5 support.


              • lylia H. @ Melanie R
                Dr. Manuel Rodrigues
                2 ans

                  Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
                  Your browser doesn't have Flash, Silverlight or HTML5 support.


                Suggestions

                Thursday, October 17th 2024 from 06pm to 07:30pm (GMT+2)
                Honolulu : Thursday, October 17th 2024 from 06am to 07:30am (GMT+2)
                San Francisco : Thursday, October 17th 2024 from 09am to 10:30am (GMT+2)
                New York : Thursday, October 17th 2024 from 12pm to 01:30pm (GMT+2)
                Buenos Aires : Thursday, October 17th 2024 from 01pm to 02:30pm (GMT+2)
                Reykjavik : Thursday, October 17th 2024 from 04pm to 05:30pm (GMT+2)
                London / Dublin : Thursday, October 17th 2024 from 05pm to 06:30pm (GMT+2)
                Paris / Berlin : Thursday, October 17th 2024 from 06pm to 07:30pm (GMT+2)
                Istanbul : Thursday, October 17th 2024 from 07pm to 08:30pm (GMT+2)
                Moscou / Dubaï : Thursday, October 17th 2024 from 08pm to 09:30pm (GMT+2)
                Bangkok : Thursday, October 17th 2024 from 11pm to 12:30am (GMT+2)
                Shanghai : Friday, October 18th 2024 from 12am to 01:30am (GMT+2)
                Tokyo : Friday, October 18th 2024 from 01am to 02:30am (GMT+2)
                Sydney : Friday, October 18th 2024 from 03am to 04:30am (GMT+2)
                Wellington : Friday, October 18th 2024 from 05am to 06:30am (GMT+2)

                La thérapie à pression négative en chirurgie mammaire

                Share
                Thursday, December 5th 2024 from 06pm to 07:30pm (GMT+1)
                Honolulu : Thursday, December 5th 2024 from 06am to 07:30am (GMT+1)
                San Francisco : Thursday, December 5th 2024 from 08am to 09:30am (GMT+1)
                New York : Thursday, December 5th 2024 from 11am to 12:30pm (GMT+1)
                Buenos Aires : Thursday, December 5th 2024 from 01pm to 02:30pm (GMT+1)
                London / Dublin : Thursday, December 5th 2024 from 04pm to 05:30pm (GMT+1)
                Paris / Berlin : Thursday, December 5th 2024 from 05pm to 06:30pm (GMT+1)
                Istanbul : Thursday, December 5th 2024 from 06pm to 07:30pm (GMT+1)
                Moscou / Dubaï : Thursday, December 5th 2024 from 08pm to 09:30pm (GMT+1)
                Bangkok : Thursday, December 5th 2024 from 11pm to 12:30am (GMT+1)
                Shanghai : Friday, December 6th 2024 from 12am to 01:30am (GMT+1)
                Tokyo : Friday, December 6th 2024 from 01am to 02:30am (GMT+1)
                Sydney : Friday, December 6th 2024 from 02am to 03:30am (GMT+1)
                Wellington : Friday, December 6th 2024 from 04am to 05:30am (GMT+1)

                Comment l'immunothérapie néoadjuvante modifie la stratégie chirurgicale ?

                Share
                Thursday, November 17th 2022 from 06pm to 07:30pm (GMT+1)
                Honolulu : Thursday, November 17th 2022 from 06am to 07:30am (GMT+1)
                San Francisco : Thursday, November 17th 2022 from 08am to 09:30am (GMT+1)
                New York : Thursday, November 17th 2022 from 11am to 12:30pm (GMT+1)
                Buenos Aires : Thursday, November 17th 2022 from 01pm to 02:30pm (GMT+1)
                London / Dublin : Thursday, November 17th 2022 from 04pm to 05:30pm (GMT+1)
                Paris / Berlin : Thursday, November 17th 2022 from 05pm to 06:30pm (GMT+1)
                Istanbul : Thursday, November 17th 2022 from 06pm to 07:30pm (GMT+1)
                Moscou / Dubaï : Thursday, November 17th 2022 from 08pm to 09:30pm (GMT+1)
                Bangkok : Thursday, November 17th 2022 from 11pm to 12:30am (GMT+1)
                Shanghai : Friday, November 18th 2022 from 12am to 01:30am (GMT+1)
                Tokyo : Friday, November 18th 2022 from 01am to 02:30am (GMT+1)
                Sydney : Friday, November 18th 2022 from 02am to 03:30am (GMT+1)
                Wellington : Friday, November 18th 2022 from 04am to 05:30am (GMT+1)

                Visible Patient : comment la planification 3D peut aider le chirurgien oncologue au quotidien ?

                Share
                Wednesday, January 24th 2024 from 06pm to 08pm (GMT+1)
                Honolulu : Wednesday, January 24th 2024 from 06am to 08am (GMT+1)
                San Francisco : Wednesday, January 24th 2024 from 08am to 10am (GMT+1)
                New York : Wednesday, January 24th 2024 from 11am to 01pm (GMT+1)
                Buenos Aires : Wednesday, January 24th 2024 from 01pm to 03pm (GMT+1)
                London / Dublin : Wednesday, January 24th 2024 from 04pm to 06pm (GMT+1)
                Paris / Berlin : Wednesday, January 24th 2024 from 05pm to 07pm (GMT+1)
                Istanbul : Wednesday, January 24th 2024 from 06pm to 08pm (GMT+1)
                Moscou / Dubaï : Wednesday, January 24th 2024 from 08pm to 10pm (GMT+1)
                Bangkok : Wednesday, January 24th 2024 from 11pm to 01am (GMT+1)
                Shanghai : Thursday, January 25th 2024 from 12am to 02am (GMT+1)
                Tokyo : Thursday, January 25th 2024 from 01am to 03am (GMT+1)
                Sydney : Thursday, January 25th 2024 from 02am to 04am (GMT+1)
                Wellington : Thursday, January 25th 2024 from 04am to 06am (GMT+1)

                The ABC of Cryoablation

                Share
                Scroll Up